Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Editorial

Epigenetic Modifications as Therapeutic Targets

Author(s): Yi-Chao Zheng and Si-Qi Feng

Volume 21 , Issue 11 , 2020

Page: [1046 - 1046] Pages: 1

DOI: 10.2174/138945012111200727122724

[1]
Goldberg AD, Allis CD, Bernstein E. Epigenetics: A Landscape Takes Shape. Cell 2007; 128: 635-8.
[2]
Pechalrieu D, Etievant C, Arimondo PB. DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies. Biochemical Pharmacology 2017; 129.
[3]
McClure JJ, Li X, Chou CJ. Chapter Six - Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics. In: Tew KD, Fisher PB, ed.^eds., Advances in Cancer Research. Academic Press 2018; pp. 183-211.
[4]
Rothbart SB, Baylin SB. Epigenetic Therapy for Epithelioid Sarcoma. Cell 2020; 181: 211.

© 2022 Bentham Science Publishers | Privacy Policy